Semaglutide reduces risk for major adverse cardiovascular events in patients with obesity and heart failure

by Elana GotkineSemaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points compared with placebo in patients with overweight or obesity and hear

Updated on: September 05,2024

Semaglutide reduces risk for major adverse cardiovascular events in patients with obesity and heart failure

by Elana GotkineSemaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points compared with placebo in patients with overweight or obesity and hear

Updated on:September 05,2024

Rising outdoor temperatures tied to higher risk for atrial fibrillation

by Lori SolomonThere is a dose-response relationship between rising outdoor temperatures and increased atrial fibrillation (AF) events, according to a study presented at the American Heart Association

Updated on: November 27,2024

Rising outdoor temperatures tied to higher risk for atrial fibrillation

by Lori SolomonThere is a dose-response relationship between rising outdoor temperatures and increased atrial fibrillation (AF) events, according to a study presented at the American Heart Association

Updated on:November 27,2024

Novel CT exam reduces need for invasive artery treatment

byRadiological Society of North AmericaCredit: MART PRODUCTION from PexelsA new study shows that a non-invasive imaging test can help identify patients with coronary artery blockage or narrowing

Updated on: April 28,2024

Novel CT exam reduces need for invasive artery treatment

byRadiological Society of North AmericaCredit: MART PRODUCTION from PexelsA new study shows that a non-invasive imaging test can help identify patients with coronary artery blockage or narrowing

Updated on:April 28,2024

Olympic Medicine: Excessive Exercise May Cause Heart Damage

Updated on: July 29,2024

Olympic Medicine: Excessive Exercise May Cause Heart Damage

Updated on:July 29,2024

Research finds preventive angioplasty does not improve prognosis

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainFor heart attack patients, treating only the coronary artery that caused the infarction works just as well as preventive balloon dilation

Updated on: April 28,2024

Research finds preventive angioplasty does not improve prognosis

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainFor heart attack patients, treating only the coronary artery that caused the infarction works just as well as preventive balloon dilation

Updated on:April 28,2024

Researchers uncover key therapeutic target involved in diabetic atherosclerosis

by Brigham and Women’s HospitalAtherosclerosis is a condition affecting the cardiovascular system. If atherosclerosis occurs in the coronary arteries (which supply the heart) the result may be an

Updated on: March 30,2024

Researchers uncover key therapeutic target involved in diabetic atherosclerosis

by Brigham and Women’s HospitalAtherosclerosis is a condition affecting the cardiovascular system. If atherosclerosis occurs in the coronary arteries (which supply the heart) the result may be an

Updated on:March 30,2024

SMART trial reaffirms hemodynamic superiority of TAVR self-expanding valve

bySociety for Cardiovascular Angiography and InterventionsCredit: Pixabay/CC0 Public DomainAdditional analysis from the SMall Annuli Randomized To Evolut or SAPIEN (SMART) study demonstrated cli

Updated on: May 07,2024

SMART trial reaffirms hemodynamic superiority of TAVR self-expanding valve

bySociety for Cardiovascular Angiography and InterventionsCredit: Pixabay/CC0 Public DomainAdditional analysis from the SMall Annuli Randomized To Evolut or SAPIEN (SMART) study demonstrated cli

Updated on:May 07,2024

On the treatment of myocardial infarction

Updated on: March 03,2025

On the treatment of myocardial infarction

Updated on:March 03,2025

Researchers prevent myocardial ischemia/reperfusion injury with oral fullerenes

by Liu Jia,Chinese Academy of SciencesThe mechanism diagram of OFNS on preventing myocardial injury in MI/RI mice. MI/RI induces hypoperfusion of intestinal tissues, which leads to the intestina

Updated on: March 30,2024

Researchers prevent myocardial ischemia/reperfusion injury with oral fullerenes

by Liu Jia,Chinese Academy of SciencesThe mechanism diagram of OFNS on preventing myocardial injury in MI/RI mice. MI/RI induces hypoperfusion of intestinal tissues, which leads to the intestina

Updated on:March 30,2024

TAVR associated with lower in-hospital complications in patients with aortic stenosis and cardiogenic shock

bySociety for Cardiovascular Angiography and InterventionsCredit: Unsplash/CC0 Public DomainA nationwide observational analysis of patients with aortic stenosis (AS) and cardiogenic shock (CS) w

Updated on: May 07,2024

TAVR associated with lower in-hospital complications in patients with aortic stenosis and cardiogenic shock

bySociety for Cardiovascular Angiography and InterventionsCredit: Unsplash/CC0 Public DomainA nationwide observational analysis of patients with aortic stenosis (AS) and cardiogenic shock (CS) w

Updated on:May 07,2024

Researchers uncover key molecule influencing vascular aging

by King's College LondonLH3 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3) deposition increases in the medial aortic layer with age and Sox9 (SRY-box transcription factor 9) expression.

Updated on: March 30,2024

Researchers uncover key molecule influencing vascular aging

by King's College LondonLH3 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3) deposition increases in the medial aortic layer with age and Sox9 (SRY-box transcription factor 9) expression.

Updated on:March 30,2024

Reduced-dose anticoagulants not noninferior for recurrent venous thromboembolism

by Elana GotkineNoninferiority of reduced- versus full-dose anticoagulants cannot be proven in patients with venous thromboembolism who need extended anticoagulation, according to a study to be presen

Updated on: December 16,2024

Reduced-dose anticoagulants not noninferior for recurrent venous thromboembolism

by Elana GotkineNoninferiority of reduced- versus full-dose anticoagulants cannot be proven in patients with venous thromboembolism who need extended anticoagulation, according to a study to be presen

Updated on:December 16,2024